. Linearity of EBA assay ( r = 0.981). The total amount of protein (50 µ g) was kept constant by mixing murine cell lysate positive for hGC (3-fold increased GC activity over NIH/ 3T3) with murine cell lysate not expressing hGC.
According to Arita et al. (1) , screening of transgenic mice is expeditiously achieved by toe clipping with subsequent analysis by PCR. This particular procedure allows one not only to achieve favorable results with regards to positive or negative genotypes of the offspring, but also to systematically numerate mouse pups for identification purposes within the same day of birth.
In this experiment, progeny of different and combined matings between heterozygous COL2A1 and heterozygous or homozygous Col11A2 mice were rigidly observed and subjected to toe clipping on the day of birth. The procedure, according to Arita et al. (1) , is shown in Table 1 .
The transgenic knock-out mice in this study are an invaluable model for the investigation of various types of bone pathology. Early-onset familial osteoarthritis and a heterogeneous group of disorders of cartilage that are known as chondrodysplasias have been linked to over 50 mutations in the COL2A1 gene (5) . Hence, the knock-out collagen type II (COL2A1) mouse is ideal for the study of these specific cartilage pathologies. Non-ocular Stickler syndrome has been found to be linked to the COL11A2gene along with linkage to autosomal dominant and recessive osteochondrodysplasias (2, 6) . The knock-out collagen Type XI mouse will certainly aid in the investigation of these bone and cartilage disorders. In addition, these mice should prove to be excellent candidates for models in gene therapy study for their respective disorders. (December 1996) Recombinant retroviral vectors for gene therapy purposes have been constructed carrying cDNA copies of genes useful for the treatment of a number of congenital or acquired diseases such as ADA deficiency (6), Gaucher's disease (7) and cancer (suicide genes) (2) . In most cases, expression of these cDNAs in a packaging cell (5) does not confer any specific drug resistance phenotype, which hampers the rapid isolation of a high-titer virus producer cell clone. We have developed a screening method, which permits rapid selection and isolation of cell clones producing high amounts of functional recombinant virus carrying a cDNA encoding a non-selectable gene product.
Dennis
The basic principle of the reported screening method is presented schematically in Figure 1 and has been worked out for retroviral vectors carrying the human lysosomal glucocerebrosidase (hGC) cDNA (4), the enzyme deficient in Gaucher patients. For the detection of the glucocerebrosidase protein, we used a primate-specific monoclonal antibody, 8E4 (1). After infection with an ecotropic recombinant retrovirus, the amphotropic retroviral packaging cells were harvested and plated on 96-well microplates at a theoretical concentration of <1 cell/well ( Figure 1, Step 1) . To increase efficiency, a 96-well pipetter was used for all handlings involving microplates. After 2-3 weeks, these cells reached 80%-100% confluency, after which the medium was replaced with fresh medium followed by an incubation for 24 h at 32°C to allow optimal virus production (3). Target cells were seeded the day before infection at a density of 2000 cells per well in 96-well microplates. For infection, cell culture supernatant from the producer clones was transferred to the target cells, and fresh medium was added to the producer cell clones ( Figure 1, Step 2). The plates containing the producer cell clones were transferred to a CO 2 incubator set at 32°C to prevent the cells from overgrowing. After an infection period of 48 h at 37°C, protein lysates were prepared from the infected target cells. The lysates were transferred to antibodycoated 96-well plates (Figure 1, Step 3) . These 96-well plates were prepared the day before by incubation with 10 µ g/ mL goat anti-mouse antibody (GAM) in phosphate-buffered saline (PBS) for 1 h at 37°C and subsequent coating with 8E4 diluted in PBS/ 0.5% bovine serum albumin (BSA) overnight at 4°C. Between steps, unbound antibodies were removed by washing with PBS. Binding of hGC by 8E4 occurred for 2 h at room temperature after which excess protein was removed by washing with lysis buffer. Glucocerebrosidase activity was detected as described (1).
Benchmark s
In Figure 2 , a typical example of results obtained using this method is given. In total, approximately 10% of the wells that contained producer cells showed 2 to 10 times increased levels of absolute units of fluorescence on infected target cells, indicating that these cells expressed hGC. The values measured are mostly within the linear range of the assay as is established using a lysate of hGC expressing murine cells (Figure 3) . Therefore, differences in fluorescence reflect differences in hGC expression. We have interpreted that high hGC expression in the infected cells reflect differences in the virus titer from the different producer clones. During the procedure, no false-positive signals were found. Producer cell confluency among different wells result in differences of not more than a factor 2, indicating that this parameter will not result in missing a relevant virus producer. Using this method, we isolated a number of virus producer clones. All the producers proved to be stably producing virus throughout the screening procedure. Virus supernatant harvested from these cell clones was used to infect Gaucher Type 1 and Type 2 primary fibroblasts and CD34 + cells from Gaucher patients. These experiments have shown that the virus producers, generated by this screening method, produce high-titer virus capable of correcting the Gaucher phenotype in primary fibroblasts and CD34 + cells and thus can be used to develop a gene therapy for Gaucher's disease.
In summary, the advantages of the reported method are as follows: (i) Large numbers of clones can easily be screened because the screening and seeding of producers are done in 96-well microplates.
(ii) The ultimate parameter of a virus producer is investigated directly, that is, the ability to produce a functional recombinant virus that transduces genes encoding (enzymatically) active gene products. (iii) Expression of endogenous protein will not interfere with the assay, and hence, retrovirus-mediated gene expression is directly measured. (iv) Alternatively, if an EBA such as described here is not available for a particular gene product, radioimmunoassay (RIA) or sandwich enzyme-linked immunosorbent assay (ELISA) can be used to detect virusmediated transfer of a particular gene product.
